Synthesis of R –GABA Derivatives via Pd(II) Catalyzed Enantioselective C(sp 3 )−H Arylation and Virtual Validation with GABA B1 Receptor for Potential leads
Chemistry – An Asian Journal · 2024
DOI: 10.1002/asia.202400064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – An Asian Journal, 2024. Verfasst von Smitha Mohanlal und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Sciences, National Institute of Science Education and Research, Bhubaneswar, Jatni, 752050. Hauptthemen laut MEDLINE: Palladium, Receptors, GABA-B, gamma-Aminobutyric Acid, Molecular Docking Simulation. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Department of Science & Technology, Government of India, Women Scientist Scheme", ESRF.
Abstract (Originalsprache)
GABA (γ–amino butyric acid) analogues like baclofen, tolibut, phenibut, etc., are well–known GABA B1 inhibitors and pharmaceutically important drugs. However, there is a huge demand for more chiral GABA aryl analogues with promising pharmacological actions. Here, we demonstrate the chiral ligand acetyl–protected amino quinoline (APAQ) mediated enantioselective synthesis of GABA B1 inhibitor drug scaffolds from easily accessible GABA via Pd–catalyzed C(sp 3 )−H activation. The synthetic methodology shows moderate to good yields, up to 74% of ee . We have successfully demonstrated the deprotection and removal of the directing group to synthesize R –tolibut in 86% yield. Further, we employed computation to probe the binding of R –GABA analogues to the extracellular domain of the human GABA B1 receptor. Our Rosetta–based molecular docking calculations show better binding for four R –enantiomers of GABA analogues than R –baclofen and R –phenibut. In addition, we employed GROMACS MD simulations and MMPB(GB)SA calculations to identify per–residue contribution to binding free energy. Our computational results suggest analogues (3 R )‐4‐amino‐3‐(3,4‐dimethylphenyl) butanoic acid, (3 R )‐4‐amino‐3‐(3‐fluorophenyl) butanoic acid, (3 R )‐3‐(4‐acetylphenyl)‐4‐aminobutanoic acid, (3 R )‐4‐amino‐3‐(4‐methoxyphenyl) butanoic acid, and (3 R )‐4‐amino‐3‐phenylbutanoic acid are potential leads which could be synthesized from our methodology reported here.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Sciences, National Institute of Science Education and Research, Bhubaneswar, Jatni, 752050.
- Homi Bhabha National Institute (HBNI), Training School Complex, Anushaktinagar, Mumbai, 400094, India.
- School of Biological Sciences, National Institute of Science Education and Research, Bhubaneswar, Jatni, 752050.
ORCID-Profile: Smitha Mohanlal, Shubhant Pandey, Rudresh Acharya, Nagendra K Sharma
Förderung
- Department of Science & Technology, Government of India
- Women Scientist Scheme"
- ESRF
- DAE
- Department of Atomic Energy, Government of India
Zitieren
APA
Mohanlal, S., Saha, D., Pandey, S., Acharya, R., & Sharma, N. K. (2024). Synthesis of R –GABA Derivatives via Pd(II) Catalyzed Enantioselective C(sp 3 )−H Arylation and Virtual Validation with GABA B1 Receptor for Potential leads. Chemistry – An Asian Journal. https://doi.org/10.1002/asia.202400064
Vancouver
Mohanlal S, Saha D, Pandey S, Acharya R, Sharma NK. Synthesis of R –GABA Derivatives via Pd(II) Catalyzed Enantioselective C(sp 3 )−H Arylation and Virtual Validation with GABA B1 Receptor for Potential leads. Chemistry – An Asian Journal. 2024. doi:10.1002/asia.202400064
BibTeX
@article{Mohanlal2024,
author = {Mohanlal, Smitha and Saha, Diprupa and Pandey, Shubhant and Acharya, Rudresh and Sharma, Nagendra K},
title = {Synthesis of R –GABA Derivatives via Pd(II) Catalyzed Enantioselective C(sp 3 )−H Arylation and Virtual Validation with GABA B1 Receptor for Potential leads},
journal = {Chemistry – An Asian Journal},
year = {2024},
doi = {10.1002/asia.202400064}
}
EUVIMED